Genetically engineered mouse models of mammary intraepithelial neoplasia

被引:51
作者
Cardiff, RD
Moghanaki, D
Jensen, RA
机构
[1] Univ Calif Davis, Dept Pathol, Davis, CA 95616 USA
[2] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA
[3] Univ Calif San Diego, Ctr Canc, Sch Med, La Jolla, CA 92093 USA
[4] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
focality; atypia; association; dysplasia;
D O I
10.1023/A:1009534129331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Foci of atypical mammary epithelium have been associated with breast cancer in many species including mouse and man. The advent of targeted genomics has led to the creation of numerous genetically engineered mice (GEM)(5) which display focal atypical lesions associated with mammary cancer. Some early lesions in GEM have a remarkable morphological similarity to pre-cancers in humans. While the malignant potential of atypical foci have been thoroughly documented in the non-GEM by tissue transplantation, a review of the literature reveals that precursor lesions in GEM remain incompletely described and only partially documented. Their validation as appropriate models of human breast preneoplasia awaits classical transplantation studies. Here, we review the literature characterizing early lesions of GEM models of mammary cancer, discuss the principles of the Focality, Atypia, and Association and present an introduction of mammary transplantation for model Validation.
引用
收藏
页码:421 / 437
页数:17
相关论文
共 127 条
[21]   The Biology of Mammary Transgenes: Five Rules [J].
Cardiff, Robert D. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 1996, 1 (01) :61-73
[22]  
CHOOI KF, 1994, CANCER RES, V54, P6434
[23]  
Dankort D L, 1996, Cancer Treat Res, V83, P71
[24]   MMTV-Fgf8 transgenic mice develop mammary and salivary gland neoplasia and ovarian stromal hyperplasia [J].
Daphna-Iken, D ;
Shankar, DB ;
Lawshé, A ;
Ornitz, DM ;
Shackleford, GM ;
MacArthur, CA .
ONCOGENE, 1998, 17 (21) :2711-2717
[25]   Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFα transgenic rats [J].
Davies, BR ;
Platt-Higgins, AM ;
Schmidt, G ;
Rudland, PS .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01) :303-314
[26]  
DeckardJanatpour K, 1997, INT J ONCOL, V11, P235
[27]   Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation [J].
Deng, CX ;
Scott, F .
ONCOGENE, 2000, 19 (08) :1059-1064
[28]  
Di Carlo E, 1999, LAB INVEST, V79, P1261
[29]   Active signaling by Neu in transgenic mice [J].
DiGiovanna, MP ;
Lerman, MA ;
Coffey, RJ ;
Muller, WJ ;
Cardiff, RD ;
Stern, DF .
ONCOGENE, 1998, 17 (14) :1877-1884
[30]   RISK-FACTORS FOR BREAST-CANCER IN WOMEN WITH PROLIFERATIVE BREAST DISEASE [J].
DUPONT, WD ;
PAGE, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (03) :146-151